Earnings summaries and quarterly performance for GE HealthCare Technologies.
Executive leadership at GE HealthCare Technologies.
Peter J. Arduini
President and Chief Executive Officer
Betty Larson
Chief People Officer
Frank Jimenez
General Counsel and Corporate Secretary
James Saccaro
Vice President and Chief Financial Officer
Kenneth Stacherski
Chief Global Supply Chain and Service Officer
Kevin O’Neill
CEO, Pharmaceutical Diagnostics
Roland Rott
President and CEO, Imaging
Taha Kass-Hout
Chief Science and Technology Officer
Thomas Westrick
CEO, Patient Care Solutions
Board of directors at GE HealthCare Technologies.
Research analysts who have asked questions during GE HealthCare Technologies earnings calls.
David Roman
Goldman Sachs Group Inc.
6 questions for GEHC
Joanne Wuensch
Citigroup Inc.
6 questions for GEHC
Robert Marcus
JPMorgan Chase & Co.
6 questions for GEHC
Vijay Kumar
Evercore ISI
6 questions for GEHC
Anthony Petrone
Mizuho Group
4 questions for GEHC
Larry Biegelsen
Wells Fargo & Company
3 questions for GEHC
Lawrence Biegelsen
Wells Fargo
3 questions for GEHC
Craig Bijou
Bank of America Securities
2 questions for GEHC
Matt Miksic
Barclays Investment Bank
2 questions for GEHC
Patrick Wood
Morgan Stanley
2 questions for GEHC
Travis Steed
Bank of America
2 questions for GEHC
Jason Bednar
Piper Sandler Companies
1 question for GEHC
Matthew Taylor
Jefferies
1 question for GEHC
Matt Taylor
Jefferies & Company Inc.
1 question for GEHC
Navann Ty Dietschi
BNP Paribas
1 question for GEHC
Rick Wise
Stifel Financial Corp
1 question for GEHC
Ryan Zimmerman
BTIG
1 question for GEHC
Recent press releases and 8-K filings for GEHC.
- GE HealthCare secured a multiyear contract under Indonesia’s SIHREN program to install over 300 CT scanners in public hospitals across 38 provinces by 2028.
- The deployment targets early diagnosis and treatment of noncommunicable diseases—such as cancer, stroke and heart disease—for Indonesia’s 280 million residents and bolsters national health system resilience.
- The agreement includes investments in local production, workforce training and technology transfer to ensure equitable access in both urban and remote areas.
- VasoHealthcare, a Vaso Corporation subsidiary, secured the fifth extension of its sales representation agreement with GE HealthCare, extending the term through December 31, 2030.
- The partnership, which began in May 2010, will span over 20 years upon the new expiration date.
- Under the amendment, VasoHealthcare will continue representing GE HealthCare’s diagnostic imaging and ultrasound portfolio—including CT, MR, molecular imaging, X-ray, mammography, and interventional guided solutions—alongside service and financial offerings.
- The extension aims to ensure continuity in sales representation and align with GE HealthCare’s commercial strategy, reinforcing both firms’ commitment to advancing diagnostic imaging solutions and patient care.
- GE HealthCare will supply over 300 CT scanners to public hospitals across 38 provinces in Indonesia by 2028 under the SIHREN program, aiming to improve early diagnosis and treatment of non-communicable diseases.
- The multiyear agreement supports the Indonesian government’s efforts to enhance diagnostic capabilities, build local manufacturing capacity, upgrade infrastructure, and facilitate knowledge transfer across urban and remote regions.
- GEHC has also teamed up with PT Kalbe Farma’s subsidiary Forsta to establish a local manufacturing facility, strengthening Indonesia’s medical device supply chain and technology transfer.
- GE HealthCare will deliver over 300 advanced CT scanners to public hospitals across 38 provinces in Indonesia by 2028, supporting early diagnosis and treatment of non-communicable diseases.
- This agreement is part of Indonesia’s SIHREN program, the country’s largest multi-year healthcare infrastructure investment to modernize its referral network and expand diagnostic access.
- To localize production and strengthen technical capacity, GE HealthCare will collaborate with PT Kalbe Farma’s subsidiary Forsta to build a domestic manufacturing facility and enhance training through the RITE training center in Jakarta.
- GE HealthCare will deliver over 300 modern CT scanners to public hospitals in 38 provinces across Indonesia by 2028 under the SIHREN program.
- The multi-year contract, awarded via a competitive Islamic Development Bank procurement process, aims to enhance early detection and treatment of non-communicable diseases and bolster national health resilience.
- SIHREN represents the largest health infrastructure investment in Indonesia’s history and one of the world’s biggest multilateral health projects, serving over 280 million people in urban and remote regions.
- The initiative builds on GE HealthCare’s ongoing investments in local manufacturing, capacity building, and knowledge transfer to strengthen the Indonesian health system.
- GE HealthCare will supply 300+ advanced CT scanners to public hospitals across 38 provinces under Indonesia’s SIHREN program by 2028.
- The multi-year contract supports early diagnosis and treatment of non-communicable diseases and aligns with the government’s healthcare modernization agenda.
- CT procurement was conducted through a competitive international tender governed by World Bank regulations.
- The agreement builds on GE HealthCare’s investment in local manufacturing, capability building and knowledge transfer to strengthen Indonesia’s healthcare ecosystem.
- SIHREN is the largest healthcare infrastructure investment in Indonesia’s history, aiming to expand diagnostic access nationwide.
- GEMINI-RT initiative launched to integrate imaging, AI, and patient monitoring across the cancer care continuum for personalized radiation therapy
- Focuses on four key areas: automation for treatment planning, predictive oncology, multimodal therapies, and connected care tools
- Research activities based at Mayo Clinic’s Rochester campus, building on a 2023 strategic radiology research collaboration and decades of prior partnership
- Aims to improve clinical outcomes, reduce clinician burnout, and expand access to personalized radiation therapy used in over 50% of cancer cases worldwide
- GE HealthCare’s business segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), pharmaceutical diagnostics (13%), with about 50% recurring revenue
- On December 1, 2025, GE HealthCare Technologies Inc. priced an underwritten offering of $600 million 4.150% Senior Notes due December 15, 2028 and $650 million 4.950% Senior Notes due December 15, 2035.
- The notes are expected to be issued on or around December 15, 2025, subject to customary closing conditions.
- A portion of the net proceeds will partially fund the acquisition of Intelerad Medical Systems; if that acquisition is not completed by November 20, 2026, the notes will be mandatorily redeemed at 101% of issue price plus accrued interest.
- Goldman Sachs & Co. LLC and BNP Paribas Securities Corp. are the representatives of the underwriters for this offering.
- GE HealthCare has submitted 510(k) filings to the FDA for its next-generation SIGNA MRI systems featuring AI-powered workflow platforms to improve exam efficiency and diagnostic precision.
- The SIGNA Bolt1 3T offers enhanced clinical efficiency and research capabilities; the SIGNA Sprint with Freelium 1.5T emphasizes sustainability and operational autonomy to broaden MRI access.
- Revenue mix: 45% imaging, 26% advanced visualization, 16% patient care, 13% pharmaceutical diagnostics; geographic sales: 46% US, 26% EMEA, 12% China, 17% rest of world, with ~50% recurring revenue.
- GE HealthCare has intensified R&D since 2022, showcasing over 40 new technology innovations at RSNA 2025 as part of its strategy to drive precision care.
- GE HealthCare has submitted its Photonova Spectra photon-counting CT system for FDA 510(k) clearance, advancing toward commercialization.
- The system uses GE’s proprietary Deep Silicon detector technology to count individual X-ray photons and measure their energy for ultra-high-definition imaging and improved tissue characterization.
- Integrated AI algorithms and NVIDIA accelerated computing enable processing of up to 50 times more data than conventional CT, aiming to enhance diagnostic confidence and streamline workflows.
- Photonova Spectra supports multiple clinical specialties—including oncology, neurology, musculoskeletal, thoracic, and cardiac imaging—through a universal scan protocol designed to improve efficiency.
Quarterly earnings call transcripts for GE HealthCare Technologies.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more